GAROFALO HEALTH CARE SPA (GHC.MI) Stock Fundamental Analysis
Europe - Euronext Milan - BIT:GHC - IT0005345233 - Common Stock
5.55 EUR
+0.06 (+1.09%)
Overall GHC gets a fundamental rating of 4 out of 10. We evaluated GHC against 32 industry peers in the Health Care Providers & Services industry. GHC has an average financial health and profitability rating. GHC has a decent growth rate and is not valued too expensively.
1. Profitability
1.1 Basic Checks
- In the past year GHC was profitable.
- In the past year GHC had a positive cash flow from operations.
- GHC had positive earnings in each of the past 5 years.
- GHC had a positive operating cash flow in each of the past 5 years.
1.2 Ratios
- GHC's Return On Assets of 3.66% is fine compared to the rest of the industry. GHC outperforms 62.50% of its industry peers.
- GHC's Return On Equity of 9.57% is in line compared to the rest of the industry. GHC outperforms 56.25% of its industry peers.
- With a decent Return On Invested Capital value of 6.52%, GHC is doing good in the industry, outperforming 65.63% of the companies in the same industry.
- GHC had an Average Return On Invested Capital over the past 3 years of 4.41%. This is below the industry average of 7.02%.
- The 3 year average ROIC (4.41%) for GHC is below the current ROIC(6.52%), indicating increased profibility in the last year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 3.66% | ||
| ROE | 9.57% | ||
| ROIC | 6.52% |
ROA(3y)2.83%
ROA(5y)2.81%
ROE(3y)7.12%
ROE(5y)6.88%
ROIC(3y)4.41%
ROIC(5y)3.91%
1.3 Margins
- GHC's Profit Margin of 4.62% is amongst the best of the industry. GHC outperforms 81.25% of its industry peers.
- GHC's Profit Margin has declined in the last couple of years.
- GHC has a better Operating Margin (9.37%) than 84.38% of its industry peers.
- In the last couple of years the Operating Margin of GHC has declined.
- GHC has a better Gross Margin (44.90%) than 68.75% of its industry peers.
- In the last couple of years the Gross Margin of GHC has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 9.37% | ||
| PM (TTM) | 4.62% | ||
| GM | 44.9% |
OM growth 3Y-0.19%
OM growth 5Y-3.37%
PM growth 3Y-11.52%
PM growth 5Y-7.03%
GM growth 3Y0.36%
GM growth 5Y-1.06%
2. Health
2.1 Basic Checks
- GHC has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
- The number of shares outstanding for GHC remains at a similar level compared to 1 year ago.
- GHC has more shares outstanding than it did 5 years ago.
- Compared to 1 year ago, GHC has an improved debt to assets ratio.
2.2 Solvency
- GHC has an Altman-Z score of 1.96. This is not the best score and indicates that GHC is in the grey zone with still only limited risk for bankruptcy at the moment.
- GHC has a Altman-Z score (1.96) which is comparable to the rest of the industry.
- The Debt to FCF ratio of GHC is 70.49, which is on the high side as it means it would take GHC, 70.49 years of fcf income to pay off all of its debts.
- GHC has a worse Debt to FCF ratio (70.49) than 75.00% of its industry peers.
- A Debt/Equity ratio of 0.67 indicates that GHC is somewhat dependend on debt financing.
- The Debt to Equity ratio of GHC (0.67) is better than 81.25% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.67 | ||
| Debt/FCF | 70.49 | ||
| Altman-Z | 1.96 |
ROIC/WACC1
WACC6.51%
2.3 Liquidity
- GHC has a Current Ratio of 1.16. This is a normal value and indicates that GHC is financially healthy and should not expect problems in meeting its short term obligations.
- The Current ratio of GHC (1.16) is better than 65.63% of its industry peers.
- A Quick Ratio of 1.12 indicates that GHC should not have too much problems paying its short term obligations.
- The Quick ratio of GHC (1.12) is better than 75.00% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.16 | ||
| Quick Ratio | 1.12 |
3. Growth
3.1 Past
- The earnings per share for GHC have decreased strongly by -12.11% in the last year.
- The Earnings Per Share has been growing by 8.81% on average over the past years. This is quite good.
- Looking at the last year, GHC shows a quite strong growth in Revenue. The Revenue has grown by 10.44% in the last year.
- The Revenue has been growing by 18.92% on average over the past years. This is quite good.
EPS 1Y (TTM)-12.11%
EPS 3Y5.52%
EPS 5Y8.81%
EPS Q2Q%2.71%
Revenue 1Y (TTM)10.44%
Revenue growth 3Y18.48%
Revenue growth 5Y18.92%
Sales Q2Q%3.08%
3.2 Future
- GHC is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 6.47% yearly.
- Based on estimates for the next years, GHC will show a small growth in Revenue. The Revenue will grow by 1.51% on average per year.
EPS Next Y3.45%
EPS Next 2Y5.05%
EPS Next 3Y6.47%
EPS Next 5YN/A
Revenue Next Year3.78%
Revenue Next 2Y4.6%
Revenue Next 3Y3.74%
Revenue Next 5Y1.51%
3.3 Evolution
- When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
- The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
- With a Price/Earnings ratio of 15.42, GHC is valued correctly.
- GHC's Price/Earnings ratio is a bit cheaper when compared to the industry. GHC is cheaper than 62.50% of the companies in the same industry.
- The average S&P500 Price/Earnings ratio is at 27.54. GHC is valued slightly cheaper when compared to this.
- The Price/Forward Earnings ratio is 17.17, which indicates a rather expensive current valuation of GHC.
- Compared to the rest of the industry, the Price/Forward Earnings ratio of GHC is on the same level as its industry peers.
- GHC's Price/Forward Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 24.31.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 15.42 | ||
| Fwd PE | 17.17 |
4.2 Price Multiples
- 81.25% of the companies in the same industry are more expensive than GHC, based on the Enterprise Value to EBITDA ratio.
- 75.00% of the companies in the same industry are cheaper than GHC, based on the Price/Free Cash Flow ratio.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 154.13 | ||
| EV/EBITDA | 7.52 |
4.3 Compensation for Growth
- The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
- GHC has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)4.47
PEG (5Y)1.75
EPS Next 2Y5.05%
EPS Next 3Y6.47%
5. Dividend
5.1 Amount
- GHC has a Yearly Dividend Yield of 1.58%.
- Compared to an average industry Dividend Yield of 1.57, GHC has a dividend in line with its industry peers.
- Compared to an average S&P500 Dividend Yield of 1.92, GHC has a dividend comparable with the average S&P500 company.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 1.58% |
5.2 History
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0
5.3 Sustainability
DPN/A
EPS Next 2Y5.05%
EPS Next 3Y6.47%
BIT:GHC (1/16/2026, 4:19:35 PM)
5.55
+0.06 (+1.09%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)11-14 2025-11-14
Earnings (Next)N/A N/A
Inst Owners11.85%
Inst Owner ChangeN/A
Ins Owners63%
Ins Owner ChangeN/A
Market Cap500.61M
Revenue(TTM)690.85M
Net Income(TTM)31.91M
Analysts84
Price Target6.73 (21.26%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 1.58% |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 15.42 | ||
| Fwd PE | 17.17 | ||
| P/S | 0.72 | ||
| P/FCF | 154.13 | ||
| P/OCF | 17.92 | ||
| P/B | 1.5 | ||
| P/tB | N/A | ||
| EV/EBITDA | 7.52 |
EPS(TTM)0.36
EY6.49%
EPS(NY)0.32
Fwd EY5.82%
FCF(TTM)0.04
FCFY0.65%
OCF(TTM)0.31
OCFY5.58%
SpS7.66
BVpS3.7
TBVpS-0.44
PEG (NY)4.47
PEG (5Y)1.75
Graham Number5.47
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 3.66% | ||
| ROE | 9.57% | ||
| ROCE | 9.13% | ||
| ROIC | 6.52% | ||
| ROICexc | 6.77% | ||
| ROICexgc | 14.86% | ||
| OM | 9.37% | ||
| PM (TTM) | 4.62% | ||
| GM | 44.9% | ||
| FCFM | 0.47% |
ROA(3y)2.83%
ROA(5y)2.81%
ROE(3y)7.12%
ROE(5y)6.88%
ROIC(3y)4.41%
ROIC(5y)3.91%
ROICexc(3y)4.63%
ROICexc(5y)4.13%
ROICexgc(3y)10.78%
ROICexgc(5y)9.37%
ROCE(3y)6.5%
ROCE(5y)5.8%
ROICexgc growth 3Y7.97%
ROICexgc growth 5Y2.8%
ROICexc growth 3Y6.71%
ROICexc growth 5Y0.74%
OM growth 3Y-0.19%
OM growth 5Y-3.37%
PM growth 3Y-11.52%
PM growth 5Y-7.03%
GM growth 3Y0.36%
GM growth 5Y-1.06%
F-Score5
Asset Turnover0.79
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.67 | ||
| Debt/FCF | 70.49 | ||
| Debt/EBITDA | 2.47 | ||
| Cap/Depr | 94.13% | ||
| Cap/Sales | 3.57% | ||
| Interest Coverage | 6.62 | ||
| Cash Conversion | 30.7% | ||
| Profit Quality | 10.18% | ||
| Current Ratio | 1.16 | ||
| Quick Ratio | 1.12 | ||
| Altman-Z | 1.96 |
F-Score5
WACC6.51%
ROIC/WACC1
Cap/Depr(3y)82.25%
Cap/Depr(5y)102.09%
Cap/Sales(3y)4.73%
Cap/Sales(5y)5.79%
Profit Quality(3y)118.21%
Profit Quality(5y)101.66%
High Growth Momentum
Growth
EPS 1Y (TTM)-12.11%
EPS 3Y5.52%
EPS 5Y8.81%
EPS Q2Q%2.71%
EPS Next Y3.45%
EPS Next 2Y5.05%
EPS Next 3Y6.47%
EPS Next 5YN/A
Revenue 1Y (TTM)10.44%
Revenue growth 3Y18.48%
Revenue growth 5Y18.92%
Sales Q2Q%3.08%
Revenue Next Year3.78%
Revenue Next 2Y4.6%
Revenue Next 3Y3.74%
Revenue Next 5Y1.51%
EBIT growth 1Y-8.88%
EBIT growth 3Y18.26%
EBIT growth 5Y14.91%
EBIT Next Year68.09%
EBIT Next 3Y22.98%
EBIT Next 5Y16.09%
FCF growth 1Y-88.34%
FCF growth 3Y4.79%
FCF growth 5Y6.69%
OCF growth 1Y-35.2%
OCF growth 3Y-1.23%
OCF growth 5Y13.09%
GAROFALO HEALTH CARE SPA / GHC.MI FAQ
What is the ChartMill fundamental rating of GAROFALO HEALTH CARE SPA (GHC.MI) stock?
ChartMill assigns a fundamental rating of 4 / 10 to GHC.MI.
What is the valuation status for GHC stock?
ChartMill assigns a valuation rating of 4 / 10 to GAROFALO HEALTH CARE SPA (GHC.MI). This can be considered as Fairly Valued.
How profitable is GAROFALO HEALTH CARE SPA (GHC.MI) stock?
GAROFALO HEALTH CARE SPA (GHC.MI) has a profitability rating of 6 / 10.
What is the financial health of GAROFALO HEALTH CARE SPA (GHC.MI) stock?
The financial health rating of GAROFALO HEALTH CARE SPA (GHC.MI) is 4 / 10.
What is the expected EPS growth for GAROFALO HEALTH CARE SPA (GHC.MI) stock?
The Earnings per Share (EPS) of GAROFALO HEALTH CARE SPA (GHC.MI) is expected to grow by 3.45% in the next year.